Notice of Redemption and Delisting

Summary by AI BETAClose X

Mortimer BTL 2021-1 PLC has announced the full redemption of its Class A, B, C, D, E, X1, and X2 Notes due 2053, along with the cancellation of its Certificates, effective June 22, 2026. Consequently, the company has requested the immediate cancellation of the listing of these notes on the Financial Conduct Authority's Official List and their admission to trading on the London Stock Exchange.

Disclaimer*

Mortimer BTL 2021-1 PLC
22 June 2026
 

RIS Notification

 

NOTICE OF REDEMPTION AND DELISTING

to the holders of the following notes and certificates of the Issuer presently outstanding

 

MORTIMER BTL 2021-1 PLC

(Registered in England and Wales under number 13340043)

(the "Issuer")

Class A Notes due 2053

(ISIN: XS2349426895)

Class B Notes due 2053

(ISIN: XS2349428164)

Class C Notes due 2053

(ISIN: XS2349428917)

Class D Notes due 2053

(ISIN: XS2349429055)

Class E Notes due 2053

(ISIN: XS2349430574)

Class X1 Notes due 2053

(ISIN: XS2349432604)

Class X2 Notes due 2053

(ISIN: XS2349434642)

(together, the "Mortimer 2021-1 Notes")

Certificate

(ISIN: XS2349445507)

(the "Certificates")

 

The Notes are admitted to the official list of the Financial Conduct Authority and to trading on the

regulated market of the London Stock Exchange.

 

Capitalised terms used but not defined in this notice shall have the same meaning as in the Prospectus dated 15 June 2021 published in connection with the Mortimer 2021-1 Notes.

 

NOTICE IS HEREBY GIVEN that the Notes have been redeemed in full and the Certificates cancelled by the Issuer on 22 June 2026. The Issuer hereby announces that they have requested the cancellation of the listing of the Notes on the Official List maintained by the Financial Conduct Authority and the Issuer's admission to trading on the London Stock Exchange plc of the Notes, effective immediately.

 

 

This notice is given on 22 June 2026 by:

Mortimer BTL 2021-1 plc

8th Floor

100 Bishopsgate

London EC2N 4AG

Disclaimer - Intended Addressees

Please note that the information contained in this announcement and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Prospectus is not addressed. Prior to relying on the information contained in this announcement you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

In particular, this announcement and the Prospectus do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Prospectus are not for distribution in the United States or to U.S. persons (as defined below) other than to qualified institutional buyers within the meaning of and in reliance on Rule 144A of the U.S. Securities Act of 1933, as amended (the Securities Act). The securities described herein have not been, and will not be, registered under the Securities Act or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. The securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the Securities Act) except pursuant to registration or an exemption from the registration requirements of the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Prospectus.

 

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings